Document is current
Any future updates will be listed below
-
Authors
Steinhoff, Bernhard J.
Leach, John Paul
- License Information
-
More Information
Article History
Received: 7 February 2026
Accepted: 23 March 2026
First Online: 1 June 2026
Declarations
:
: Not applicable.
: Not applicable.
: BJS: Advisory and consulting honoraria: Angelini Pharma, Jazz/GW Pharmaceuticals, Neuraxpharm, Polpharm Speaker’s honoraria: Angelini, Desitin, German Neurological Society, Eisai, Medscape, Neuraxpharm, UCB. Research support: Eisai, European Union, Jannsen-Cilag, Jazz/GW Pharmaceuticals, Neuraxpharm, SK Life Sciences, UCB, Zogenix. JPL: Full-time employee of Angelini Pharma. Advisory and consulting honoraria: Angelini Pharma, Jazz/GW Pharmaceuticals, Precisis, Roche Diagnostics, UCB. Speaker’s honoraria: Al Jazeera, Angelini Pharma, Arvelle Therapeutics, Desitin, Eisai, Pfizer, GSK, UCB. Research support: UCB.
